Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL

 IMAGE   06/2020

Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service